Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
Major Depressive Disorder
About this trial
This is an interventional treatment trial for Major Depressive Disorder focused on measuring Resistance Exercise
Eligibility Criteria
Inclusion Criteria: Be diagnosed with DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) MDD confirmed via Structured Clinical Interview for DSM-5 Have current depressive symptoms of at least mild severity defined by a Hamilton Rating Scale of Depression score greater than or equal to 8 Be ages 18-65 Have not changed psychological treatments (including drugs, behavioral and psychological treatments) in the past 8 weeks and willing to maintain treatments throughout study enrollment Safe to exercise based on Physical Activity Readiness Questionnaire (PARQ) responses Exclusion Criteria: Currently pregnant, nursing, or planning to become pregnant during the study Currently diagnosed with a drug or alcohol use disorder (via SCID) Comorbid psychiatric conditions confirmed via SCID, with the exception of Generalized Anxiety Disorder (GAD; due to high comorbidity) Class II or greater level of obesity (BMI greater than or equal to 35) High active suicidal ideation with specific plan and intent ('4' or '5' score on Suicidal Ideation from Columbia Suicide Severity Rating Scale or '3' on QIDS) Currently meets US resistance exercise recommendations per week (2 days per week) for the last 8 weeks Self-reported prior cardiovascular event or condition, stroke or pulmonary, renal, or neurological disease Self-reported diabetes mellitus Self-reported recent (within 3 months) severe concussion, in which the individual lost consciousness for any amount of time Self-reported smoking/vaping
Sites / Locations
- Iowa State University
Arms of the Study
Arm 1
Experimental
Resistance Exercise Training
Participants will complete a 16-week, twice/week program to increase strength.